NCT02516319View on ClinicalTrials.gov

Liver Function Assessment - Feasibility and Dosing Study

NATerminatedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Hepatic Failure
Interventions
DRUG

ICG Dye

Sponsors
All Listed Sponsors
lead

Cardiox Corporation

INDUSTRY